DHG Pharmaceutical JSC Cash Flow Quality Index
DHG Pharmaceutical JSC cash flow quality index. DHG Pharmaceutical JSC (DHG) has a Cash Flow Quality Index of 0.72x as of June 2026. Operating cash flow of ₫214.23 Billion is below net income of ₫298.67 Billion, suggesting accrual-heavy earnings not yet converted to cash. See DHG Pharmaceutical JSC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of DHG Pharmaceutical JSC (2019–2025)
Cash flow quality index of DHG Pharmaceutical JSC from 2019 to 2025. Historical Cash Flow Quality Index for DHG Pharmaceutical JSC across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of DHG Pharmaceutical JSC to assess how comfortably operating cash covers total debt obligations.
DHG Pharmaceutical JSC Cash Flow Quality Index by Year (2019–2025)
DHG Pharmaceutical JSC cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for DHG Pharmaceutical JSC. For the full cash flow conversion analysis, see DHG cash generation efficiency.
| Year | Quality Index | Operating CF (VND) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.42x | ₫1.21 Trillion | ₫852.35 Billion | ▼ -15.9% |
| 2024 | 1.69x | ₫1.32 Trillion | ₫778.92 Billion | ▲ +535.5% |
| 2023 | 0.27x | ₫279.88 Billion | ₫1.05 Trillion | ▼ -70.8% |
| 2022 | 0.91x | ₫901.28 Billion | ₫988.45 Billion | ▲ +56.6% |
| 2021 | 0.58x | ₫452.44 Billion | ₫777.22 Billion | ▼ -47.9% |
| 2020 | 1.12x | ₫826.17 Billion | ₫739.87 Billion | ▼ -15.4% |
| 2019 | 1.32x | ₫838.24 Billion | ₫635.39 Billion | — |